Retinitis Pigmentosa: all 273 studies
Page 2 of 3. Open to participants first (71), then studies with results posted, then the rest; newest registration first within each.
- An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis PigmentosaCompletedNCT00661479Phase 1/2Results posted
- A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis PigmentosaCompletedNCT00447993Phase 2Results posted
- A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis PigmentosaCompletedNCT00447980Phase 2Results posted
- Argus® II Retinal Stimulation System Feasibility ProtocolCompletedNCT00407602Not applicableResults posted
- Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin ACompletedNCT00346333Phase 3Results posted
- Feasibility Study of a Chronic Retinal Stimulator in Retinitis PigmentosaCompletedNCT00279500Not applicableResults posted
- DHA and X-Linked Retinitis PigmentosaCompletedNCT00100230Phase 2Results posted
- Intravitreal Adalimumab in Inherited and Degenerative Retinal DiseasesActive, not recruitingNCT07348588Phase 1/2
- Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal DiseasesActive, not recruitingNCT07341919Phase 1/2
- Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)Active, not recruitingNCT06912633Phase 2
- Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A GeneActive, not recruitingNCT06627179Phase 2
- Expanded Access Program for RP in AdultsNo longer availableNCT06574997
- A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)Active, not recruitingNCT06517940
- Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION)Active, not recruitingNCT06460844Phase 1
- A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis PigmentosaActive, not recruitingNCT06388200Phase 3
- Clinical and Genetic Findings in Patients With PRPF31-associated Retinitis PigmentosaCompletedNCT06368375
- A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (SKYLINE)Active, not recruitingNCT06333249Phase 2
- Natural History Study in Patients With PDE6A-, PDE6B- and RHO-linked Retinitis PigmentosaActive, not recruitingNCT06323772
- Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE StudyActive, not recruitingNCT06162585
- A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis PigmentosaActive, not recruitingNCT05926583Phase 3
- In Depth Observational Clinical Trial Of Retinitis Pigmentosa PatientsStatus unknownNCT05849987
- Intravitreal Quantum Dots (QD) for Advanced Retinitis Pigmentosa (RP) (QUANTUM)WithdrawnNCT05841862Not applicable
- Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDTCompletedNCT05820100
- Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and MagnovisionCompletedNCT05800301Phase 3
- Mechanisms of Inherited Retinal Dystrophies Using Whole Genome Sequencing and in Vitro and in Vivo ModelsCompletedNCT05793515
- Promising ROd-cone DYstrophy Gene therapYActive, not recruitingNCT05748873Phase 1/2
- Spheroidal Mesenchymal Stem Cells in Retinitis PigmentosaCompletedNCT05712148Phase 1/2
- Natural History of PRPF31 Mutation-Associated Retinal DystrophyActive, not recruitingNCT05573984
- Oral N-acetylcysteine for Retinitis PigmentosaActive, not recruitingNCT05537220Phase 3
- The Effect of Stem Cells and Stem Cell Exosomes on Visual Functions in Patients With Retinitis PigmentosaStatus unknownNCT05413148Phase 2/3
- Characterizing the Genotype and Phenotype in Adults With Bardet-Biedl SyndromeCompletedNCT05400278
- Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis PigmentosaTerminatedNCT05392751Phase 1/2
- A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)CompletedNCT05282953Phase 1/2
- CArotenoid in hypoChOlesterolemiaCompletedNCT05208879
- Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital AmaurosisActive, not recruitingNCT05203939Phase 1/2
- A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary RetinopathyCompletedNCT05179460
- Retrospective NIS to Evaluate the Patient Benefit of TESCompletedNCT04983914
- Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]CompletedNCT04945772Phase 2
- Natural History of the Progression of X-Linked Retinitis PigmentosaCompletedNCT04926129
- Phase 1 Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis PigmentosaCompletedNCT04925687Phase 1
- Dose-Escalation Study to Evaluate the Safety and Tolerability of Intravitreal vMCO-I in Patients With Advanced Retinitis PigmentosaCompletedNCT04919473Phase 1/2
- Pupil Dynamics and Color Vision for the Detection of Eye DiseasesCompletedNCT04909398Not applicable
- An Observational Study of Japanese Participants With X-linked Retinitis PigmentosaCompletedNCT04868916
- Effects of Treatment With N- Acetylcysteine on Visual Outcomes in Patients With Retinitis PigmentosaStatus unknownNCT04864496Phase 2
- Characterizing Rate of Progression in USHer Syndrome (CRUSH) StudyStatus unknownNCT04820244
- Natural History Study of Retinitis Pigmentosa Type 11Active, not recruitingNCT04805658
- Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1FActive, not recruitingNCT04765345
- Investigation of Therapeutic Efficacy and Safety of UMSCs for the Management of Retinitis Pigmentosa (RP)Status unknownNCT04763369Phase 2
- Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus PhotographCompletedNCT04723160
- CNGB1 and Allied DisordersSuspendedNCT04639635
- CB-PRP in Retinitis Pigmentosa and Dry Age-related Macular DegenerationCompletedNCT04636853Phase 3
- Bimodal and Coaxial High Resolution Ophtalmic ImagingStatus unknownNCT04620876Not applicable
- PDE6A Gene Therapy for Retinitis PigmentosaActive, not recruitingNCT04611503Phase 1/2
- A Natural History Study to Evaluate Functional and Anatomical Progression in Retinitis PigmentosaTerminatedNCT04558983
- Natural History of Patients With Inherited Retinal Diseases Due to Mutations in RPE65 GeneCompletedNCT04525261
- 4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)Active, not recruitingNCT04517149Phase 1/2
- Validation of Standardized Test Protocols to Assess the Impact of Visual Pathologies in Daily Life ActivitiesStatus unknownNCT04448860Not applicable
- Mobility Protocol Adapted for Advanced Visually Impaired SubjectsStatus unknownNCT04419285Not applicable
- Impact of Visual Field Restriction on Visual ExplorationStatus unknownNCT04360291
- Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis PigmentosaCompletedNCT04315025Phase 1/2
- NR600 System Retinal Prosthesis for Patients With Retinal Degenerative DiseasesTerminatedNCT04295304Not applicable
- Prospective Natural History Study of Retinitis PigmentosaActive, not recruitingNCT04285398Not applicable
- CNS10-NPC for the Treatment of RPActive, not recruitingNCT04284293Phase 1
- Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced VisionCompletedNCT04281732
- Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich PlasmaCompletedNCT04252534Not applicable
- Effects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis PigmentosaCompletedNCT04238858Not applicable
- Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yellow LaserCompletedNCT04234438Not applicable
- Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem CellsCompletedNCT04224207Phase 3
- High Resolution Retina ImagingStatus unknownNCT04128150
- Rate of Progression in EYS Related Retinal DegenerationCompletedNCT04127006
- A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO GeneActive, not recruitingNCT04123626Phase 1/2
- Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)TerminatedNCT04120883Phase 1/2
- Minocycline Treatment in Retinitis PigmentosaCompletedNCT04068207Phase 2
- Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal DiseasesCompletedNCT04008771Not applicable
- FIGHT-RP 1 Extension StudyActive, not recruitingNCT03999021Phase 1
- A New Treatment of Retinitis PigmentosaStatus unknownNCT03998384Not applicable
- Evaluation of the Visual Field on the GroundWithdrawnNCT03989622Not applicable
- Retrospective Natural History Study of Retinitis PigmentosaStatus unknownNCT03975543
- Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic MutationActive, not recruitingNCT03963154Phase 1/2
- Safety and Efficacy of Subretinal Transplantation of Clinical Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Retinitis PigmentosaActive, not recruitingNCT03944239Phase 1
- Prospective Open Clinical and Genetic Study of Patients With Retinitis PigmentosaCompletedNCT03901391
- Retinitis Pigmentosa Clinical Measures and Repeatability Testing of Potential Outcome MeasuresCompletedNCT03845218
- Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A GeneCompletedNCT03780257Phase 1/2
- Stem Cells Therapy in Degenerative Diseases of the RetinaStatus unknownNCT03772938Phase 1
- Experimental and Clinical Studies of Retinal StimulationStatus unknownNCT03635645Not applicable
- RETINA IMPLANT Alpha AMS in Blind Patients With Retinitis PigmentosaWithdrawnNCT03629899Not applicable
- Development of Visual Function Evaluation Method (2)CompletedNCT03626207
- Long-term Follow-up Study in Subjects Who Received Voretigene Neparvovec-rzyl (AAV2-hRPE65v2)Active, not recruitingNCT03602820
- A Patient Registry Study for Patients Treated With Voretigene Neparvovec in USCompletedNCT03597399
- Treatment of RP and LCA by Primary RPE TransplantationStatus unknownNCT03566147Early Phase 1
- Self-confidence Study in Patients With Argus II Artificial RetinaStatus unknownNCT03510234
- Argus II Retinal Prosthesis System - Better Vision RP StudyWithdrawnNCT03418116Not applicable
- Study of a Suprachoroidal Retinal ProsthesisCompletedNCT03406416Not applicable
- Exercise and RP (AVAMC and Emory)CompletedNCT03381235Not applicable
- A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis PigmentosaCompletedNCT03374657Phase 1/2
- Effectiveness of a Cognitive-behavioral Program of Coping With Psychological Stress in People With Retinitis PigmentosaCompletedNCT03368027Not applicable
- Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR)CompletedNCT03349242
- Safety and Efficacy Study in Patients With Retinitis Pigmentosa Due to Mutations in PDE6B GeneTerminatedNCT03328130Phase 1/2
- Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis PigmentosaActive, not recruitingNCT03326336Phase 1/2
- Clinical and Genetic Testing of Patients With Usher SyndromeCompletedNCT03319524